vs
Side-by-side financial comparison of HARROW, INC. (HROW) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $78.6M, roughly 1.1× Repay Holdings Corp). HARROW, INC. runs the higher net margin — 7.4% vs -178.3%, a 185.7% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 0.4%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -1.3%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
HROW vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $78.6M |
| Net Profit | $6.6M | $-140.1M |
| Gross Margin | 79.3% | 74.2% |
| Operating Margin | 17.5% | -182.2% |
| Net Margin | 7.4% | -178.3% |
| Revenue YoY | 33.3% | 0.4% |
| Net Profit YoY | -2.2% | -3304.1% |
| EPS (diluted) | $0.20 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $78.6M | ||
| Q3 25 | $71.6M | $77.7M | ||
| Q2 25 | $63.7M | $75.6M | ||
| Q1 25 | $47.8M | $77.3M | ||
| Q4 24 | $66.8M | $78.3M | ||
| Q3 24 | $49.3M | $79.1M | ||
| Q2 24 | $48.9M | $74.9M | ||
| Q1 24 | $34.6M | $80.7M |
| Q4 25 | $6.6M | $-140.1M | ||
| Q3 25 | $1.0M | $-6.4M | ||
| Q2 25 | $5.0M | $-102.3M | ||
| Q1 25 | $-17.8M | $-7.9M | ||
| Q4 24 | $6.8M | $-4.1M | ||
| Q3 24 | $-4.2M | $3.2M | ||
| Q2 24 | $-6.5M | $-4.1M | ||
| Q1 24 | $-13.6M | $-5.2M |
| Q4 25 | 79.3% | 74.2% | ||
| Q3 25 | 75.3% | 74.4% | ||
| Q2 25 | 74.5% | 75.7% | ||
| Q1 25 | 67.5% | 75.9% | ||
| Q4 24 | 78.8% | 76.3% | ||
| Q3 24 | 75.6% | 77.8% | ||
| Q2 24 | 74.4% | 78.2% | ||
| Q1 24 | 69.5% | 76.2% |
| Q4 25 | 17.5% | -182.2% | ||
| Q3 25 | 20.6% | -3.9% | ||
| Q2 25 | 17.9% | -138.7% | ||
| Q1 25 | -23.5% | -4.7% | ||
| Q4 24 | 19.3% | -1.5% | ||
| Q3 24 | 2.7% | -0.9% | ||
| Q2 24 | 3.1% | -4.6% | ||
| Q1 24 | -20.0% | -3.1% |
| Q4 25 | 7.4% | -178.3% | ||
| Q3 25 | 1.4% | -8.3% | ||
| Q2 25 | 7.8% | -135.2% | ||
| Q1 25 | -37.2% | -10.3% | ||
| Q4 24 | 10.1% | -5.3% | ||
| Q3 24 | -8.6% | 4.1% | ||
| Q2 24 | -13.2% | -5.4% | ||
| Q1 24 | -39.2% | -6.5% |
| Q4 25 | $0.20 | $-1.68 | ||
| Q3 25 | $0.03 | $-0.08 | ||
| Q2 25 | $0.13 | $-1.15 | ||
| Q1 25 | $-0.50 | $-0.09 | ||
| Q4 24 | $0.19 | $-0.04 | ||
| Q3 24 | $-0.12 | $0.03 | ||
| Q2 24 | $-0.18 | $-0.04 | ||
| Q1 24 | $-0.38 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $115.7M |
| Total DebtLower is stronger | $250.0M | $280.1M |
| Stockholders' EquityBook value | $52.4M | $484.4M |
| Total Assets | $399.5M | $1.2B |
| Debt / EquityLower = less leverage | 4.77× | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $115.7M | ||
| Q3 25 | $74.3M | $95.7M | ||
| Q2 25 | $53.0M | $162.6M | ||
| Q1 25 | $66.7M | $165.5M | ||
| Q4 24 | $47.2M | $189.5M | ||
| Q3 24 | $72.6M | $168.7M | ||
| Q2 24 | $71.0M | $147.1M | ||
| Q1 24 | $76.0M | $128.3M |
| Q4 25 | $250.0M | $280.1M | ||
| Q3 25 | $347.2M | $279.5M | ||
| Q2 25 | $250.6M | $279.0M | ||
| Q1 25 | $256.9M | $497.6M | ||
| Q4 24 | $262.7M | $496.8M | ||
| Q3 24 | $230.7M | $496.2M | ||
| Q2 24 | $236.3M | $435.6M | ||
| Q1 24 | $243.4M | $434.9M |
| Q4 25 | $52.4M | $484.4M | ||
| Q3 25 | $47.0M | $616.9M | ||
| Q2 25 | $49.7M | $633.7M | ||
| Q1 25 | $56.5M | $755.7M | ||
| Q4 24 | $69.7M | $761.3M | ||
| Q3 24 | $58.0M | $754.7M | ||
| Q2 24 | $58.5M | $815.4M | ||
| Q1 24 | $60.6M | $813.8M |
| Q4 25 | $399.5M | $1.2B | ||
| Q3 25 | $363.1M | $1.3B | ||
| Q2 25 | $345.0M | $1.4B | ||
| Q1 25 | $364.2M | $1.5B | ||
| Q4 24 | $389.0M | $1.6B | ||
| Q3 24 | $351.5M | $1.6B | ||
| Q2 24 | $306.6M | $1.5B | ||
| Q1 24 | $295.5M | $1.5B |
| Q4 25 | 4.77× | 0.58× | ||
| Q3 25 | 7.39× | 0.45× | ||
| Q2 25 | 5.05× | 0.44× | ||
| Q1 25 | 4.55× | 0.66× | ||
| Q4 24 | 3.77× | 0.65× | ||
| Q3 24 | 3.98× | 0.66× | ||
| Q2 24 | 4.04× | 0.53× | ||
| Q1 24 | 4.02× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $23.3M |
| Free Cash FlowOCF − Capex | $8.1M | $23.2M |
| FCF MarginFCF / Revenue | 9.1% | 29.6% |
| Capex IntensityCapex / Revenue | 0.4% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $23.3M | ||
| Q3 25 | $16.6M | $32.2M | ||
| Q2 25 | $-803.0K | $33.1M | ||
| Q1 25 | $19.7M | $2.5M | ||
| Q4 24 | $-17.8M | $34.3M | ||
| Q3 24 | $3.0M | $60.1M | ||
| Q2 24 | $-2.7M | $31.0M | ||
| Q1 24 | $-4.6M | $24.8M |
| Q4 25 | $8.1M | $23.2M | ||
| Q3 25 | $16.4M | $32.1M | ||
| Q2 25 | $-969.0K | $33.0M | ||
| Q1 25 | $19.5M | $2.4M | ||
| Q4 24 | $-18.3M | $34.0M | ||
| Q3 24 | $2.3M | $59.8M | ||
| Q2 24 | $-3.1M | $30.5M | ||
| Q1 24 | $-4.7M | $24.7M |
| Q4 25 | 9.1% | 29.6% | ||
| Q3 25 | 22.9% | 41.3% | ||
| Q2 25 | -1.5% | 43.6% | ||
| Q1 25 | 40.8% | 3.0% | ||
| Q4 24 | -27.4% | 43.5% | ||
| Q3 24 | 4.8% | 75.6% | ||
| Q2 24 | -6.3% | 40.7% | ||
| Q1 24 | -13.6% | 30.6% |
| Q4 25 | 0.4% | 0.1% | ||
| Q3 25 | 0.3% | 0.2% | ||
| Q2 25 | 0.3% | 0.1% | ||
| Q1 25 | 0.4% | 0.2% | ||
| Q4 24 | 0.8% | 0.3% | ||
| Q3 24 | 1.2% | 0.3% | ||
| Q2 24 | 0.7% | 0.6% | ||
| Q1 24 | 0.3% | 0.1% |
| Q4 25 | 1.27× | — | ||
| Q3 25 | 16.26× | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.62× | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
